echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Two exclusive formulations of 600 million anti-allergic drug companies have been reviewed

    Two exclusive formulations of 600 million anti-allergic drug companies have been reviewed

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today (March 17), the official website of NMPA showed that Puli Pharmaceutical's desloratadine dispersible tablets and desloratadine dry suspension passed the consistency evaluation.


    Desloratadine is a non-sedating long-acting tricyclic antihistamine and the active metabolite of loratadine.


    According to data from Minai.


    Brand pattern of the terminal desloratadine in China's public medical institutions in 2019

    Source: Mi Nei.


    The desloratadine products currently on the market in China include desloratadine tablets, desloratadine dispersible tablets, desloratadine dry suspension, desloratadine capsules, desloratadine syrup and Deloratadine oral solution.


    The oral constant-release dosage form of desloratadine has been included in the third batch of centralized procurement.


    Source: Mi Neiwang database, NMPA

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.